Karo Healthcare has expanded its OTC offering in Italy with the acquisition of hemorrhoid treatment Proctosedyl from Bayer for an undisclosed sum.
Under the terms of the asset deal, Karo gains exclusive license to the Proctosedyl trademark in Italy, as well as...